Neurogene Inc. Quarterly Common Stock, Shares, Issued from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Neurogene Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2013 to Q3 2024.
  • Neurogene Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 13M shares, a 47.8% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 13M +4.21M +47.8% Sep 30, 2024 10-Q 2024-11-18
Q2 2024 13M -31M -70.5% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 12.9M -30M -70% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 12.8M +12.8M Dec 31, 2023 10-Q 2024-11-18
Q3 2023 8.81M -33.8M -79.3% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 44M +1.44M +3.39% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 42.8M +324K +0.76% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 0 -42.5M -100% Dec 31, 2022 10-K 2024-03-18
Q3 2022 42.6M +166K +0.39% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 42.6M +161K +0.38% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 42.5M +168K +0.4% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 42.5M +261K +0.62% Dec 31, 2021 10-K 2023-03-20
Q3 2021 42.4M +552K +1.32% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 42.4M +3.93M +10.2% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 42.3M +3.94M +10.3% Mar 31, 2021 10-Q 2021-05-12
Q4 2020 42.2M +4.2M +11.1% Dec 31, 2020 10-K 2022-03-01
Q3 2020 41.9M +13.7M +48.8% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 38.5M +14.9M +63.5% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 38.4M +14.8M +63.1% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 38M +14.5M +61.4% Dec 31, 2019 10-K 2021-03-25
Q3 2019 28.1M +4.6M +19.6% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 23.5M 0 0% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 23.5M +45.2K +0.19% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 23.5M +64.9K +0.28% Dec 31, 2018 10-K 2020-03-12
Q3 2018 23.5M +72.4K +0.31% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 23.5M +72.7K +0.31% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 23.5M +69K +0.3% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 23.5M +49.3K +0.21% Dec 31, 2017 10-K 2019-03-07
Q3 2017 23.5M +41.8K +0.18% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 23.5M +6.25M +36.3% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 23.4M +6.21M +36.1% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 23.4M +6.21M +36.1% Dec 31, 2016 10-K 2018-03-12
Q3 2016 23.4M +6.21M +36.1% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 17.2M +6.49M +60.5% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 17.2M +6.49M +60.5% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 17.2M +6.52M +60.9% Dec 31, 2015 10-K 2017-03-09
Q3 2015 17.2M Sep 30, 2015 10-Q 2015-11-10
Q2 2015 10.7M Jun 30, 2015 10-Q 2015-08-06
Q1 2015 10.7M Mar 31, 2015 10-Q 2015-05-12
Q4 2014 10.7M +10.4M +3444% Dec 31, 2014 10-K 2016-03-14
Q4 2013 302K Dec 31, 2013 10-K 2015-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.